The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

Item
http://www.wikidata.org/entity/Q26829564
The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraineSerotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan.Emerging treatment for chronic migraine and refractory chronic migraine.Update on future headache treatments.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs.Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors.PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cellsEpisodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists.Lasmiditan for the treatment of migraine.Triptans and migraine: advances in use, administration, formulation, and development.Advances in drug development for acute migraine.The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.Targeted 5-HT1F Therapies for Migraine.The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers
P2860

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

Item
http://www.wikidata.org/entity/Q26829564
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@ast
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@en
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@nl
type
label
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@ast
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@en
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@nl
prefLabel
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@ast
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@en
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@nl
P1433
P1476
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
The 5-HT1F receptor agonist la ...... ebo-controlled phase II trials
@en
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932